Work

A novel risk stratification model based on the Children's Hepatic Tumours International Collaboration-Hepatoblastoma Stratification and deoxyribonucleic acid methylation analysis for hepatoblastoma

Year: 2022

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2022.06.013

Authors: Takafumi Kondo, Shohei Honda, Hiromu Suzuki, Yoichi M. Ito, Issei Kawakita, Kazuyoshi Okumura, Momoko Ara, Masashi Minato, Norihiko Kitagawa, Yukichi Tanaka, Mio Tanaka, Masato Shinkai, Tomoro Hishiki, Kenichiro Watanabe, Kohmei Ida, Atsushi Takatori, Eiso Hiyama, Akinobu Taketomi

Institutions: Hokkaido University, Sapporo Medical University, Hokkaido University Hospital, Kanagawa Children's Medical Center, Chiba University, Shizuoka Children's Hospital, Teikyo University Hospital, Mizonokuchi, Teikyo University, Chiba Cancer Center Research Institute, Natural Science Center for Basic Research and Development, Hiroshima University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Takeda Pharmaceutical Company, Uehara Memorial Foundation, Japan Society for the Promotion of Science

Awards: Epigenetic aberrations associated with evolution of hepatoblastoma, Selection of new molecular markers for risk stratification of pediatric liver tumors based on integrated genomic analysis, Molecular analyses of hepatoblastoma based on common mechanism with hepatocellular carcinoma, Methylation analyses related to CDDP-resistant hepatoblastoma, G5812596820, DOT1L阻害によるインターフェロン応答の機序解明とがん免疫療法への応用

OpenAlex ID: W4284967646

FWCI: 3.823

Cites: 23

Cited by: 31

Related to: 10